ZA80902B - N-substituted aziridine-2-carboxylic acid derivatives - Google Patents

N-substituted aziridine-2-carboxylic acid derivatives

Info

Publication number
ZA80902B
ZA80902B ZA00800902A ZA80902A ZA80902B ZA 80902 B ZA80902 B ZA 80902B ZA 00800902 A ZA00800902 A ZA 00800902A ZA 80902 A ZA80902 A ZA 80902A ZA 80902 B ZA80902 B ZA 80902B
Authority
ZA
South Africa
Prior art keywords
carboxylic acid
acid derivatives
substituted aziridine
aziridine
substituted
Prior art date
Application number
ZA00800902A
Other languages
English (en)
Inventor
U Bicker
W Kampe
E Bosies
M Thiel
D Boerner
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA80902B publication Critical patent/ZA80902B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA00800902A 1979-02-21 1980-02-18 N-substituted aziridine-2-carboxylic acid derivatives ZA80902B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792906603 DE2906603A1 (de) 1979-02-21 1979-02-21 N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ZA80902B true ZA80902B (en) 1981-03-25

Family

ID=6063481

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00800902A ZA80902B (en) 1979-02-21 1980-02-18 N-substituted aziridine-2-carboxylic acid derivatives

Country Status (19)

Country Link
US (2) US4397848A (enEXAMPLES)
EP (1) EP0014976B1 (enEXAMPLES)
JP (1) JPS55113760A (enEXAMPLES)
AR (1) AR223863A1 (enEXAMPLES)
AT (1) ATE818T1 (enEXAMPLES)
AU (1) AU529982B2 (enEXAMPLES)
CA (1) CA1148962A (enEXAMPLES)
CS (1) CS208798B2 (enEXAMPLES)
DD (1) DD148772A5 (enEXAMPLES)
DE (2) DE2906603A1 (enEXAMPLES)
ES (1) ES488656A1 (enEXAMPLES)
FI (1) FI70702C (enEXAMPLES)
HU (1) HU182801B (enEXAMPLES)
IE (1) IE49267B1 (enEXAMPLES)
IL (1) IL59425A (enEXAMPLES)
PL (1) PL129707B1 (enEXAMPLES)
PT (1) PT70847A (enEXAMPLES)
SU (1) SU1181541A3 (enEXAMPLES)
ZA (1) ZA80902B (enEXAMPLES)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925835A (en) * 1986-05-01 1990-05-15 Sloan-Kettering Institute For Cancer Research Aziridinyl putrescine containing compositions and their uses in treating prostate cancer
JPH07301287A (ja) * 1995-03-23 1995-11-14 Sumitomo Heavy Ind Ltd 制御装置に用いられる内接噛合遊星歯車機構
CA2294243C (en) 1997-06-27 2008-12-30 Arizona Board Of Regents, University Of Arizona Novel cyanoaziridines for treating cancer
US20030129222A1 (en) * 2000-11-21 2003-07-10 Gabriel Lopez-Berestein Liposomal imexon
WO2002041871A2 (en) * 2000-11-21 2002-05-30 Board Of Regents, The University Of Texas System Composition comprising an imexon or derivatives thereof and lipids
EP1455763B1 (en) * 2001-12-21 2007-10-03 Supernus Pharmaceuticals, Inc. Oral capsule formulation with increased physical stability
US20040005339A1 (en) * 2002-06-28 2004-01-08 Shojaei Amir H. Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
RS20050532A (en) 2003-01-14 2007-12-31 Arena Pharmaceuticals Inc., 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US20070066590A1 (en) * 2003-02-24 2007-03-22 Jones Robert M Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
ATE415397T1 (de) * 2004-06-04 2008-12-15 Arena Pharm Inc Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen
MY148521A (en) * 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
EA013084B1 (ru) * 2005-09-16 2010-02-26 Арена Фармасьютикалз, Инк. Модуляторы метаболизма и лечение связанных с ним нарушений
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
SG10201500639TA (en) 2010-01-27 2015-03-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
CA2812061A1 (en) 2010-09-22 2012-03-29 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
UA126268C2 (uk) 2015-01-06 2022-09-14 Арена Фармасьютікалз, Інк. СПОСОБИ ЛІКУВАННЯ СТАНІВ, ПОВ'ЯЗАНИХ З РЕЦЕПТОРОМ S1P<sub>1 </sub>
DK3310760T3 (da) 2015-06-22 2022-10-24 Arena Pharm Inc Krystallinsk L-argininsalt af (R)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3- yl)eddikesyre til anvendelse ved S1P1-receptor-associerede lidelser
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
MX2020013157A (es) 2018-06-06 2021-04-29 Arena Pharm Inc Métodos de tratamiento de afecciones relacionadas con el receptor s1p1.
CN113816887A (zh) * 2021-08-31 2021-12-21 华中科技大学 一种氮杂环丙烷类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2644820A1 (de) * 1976-10-05 1978-04-06 Boehringer Mannheim Gmbh Cancerostatisch und immunstimulierend wirkende 1-(n-acyl-carbamoyl)-2-cyanaziridine sowie verfahren zur herstellung derselben
DE2731264A1 (de) 1977-07-11 1979-02-01 Boehringer Mannheim Gmbh Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
US4397848A (en) 1983-08-09
IL59425A0 (en) 1980-05-30
EP0014976B1 (de) 1982-04-07
HU182801B (en) 1984-03-28
AU529982B2 (en) 1983-06-30
PL129707B1 (en) 1984-06-30
ATE818T1 (de) 1982-04-15
JPH0150700B2 (enEXAMPLES) 1989-10-31
IL59425A (en) 1984-05-31
FI800510A7 (fi) 1980-08-22
EP0014976A1 (de) 1980-09-03
CS208798B2 (en) 1981-09-15
AR223863A1 (es) 1981-09-30
CA1148962A (en) 1983-06-28
US4517183A (en) 1985-05-14
SU1181541A3 (ru) 1985-09-23
DE2906603A1 (de) 1980-09-04
PL222088A1 (enEXAMPLES) 1980-12-01
JPS55113760A (en) 1980-09-02
PT70847A (de) 1980-03-01
FI70702B (fi) 1986-06-26
DD148772A5 (de) 1981-06-10
DE3060268D1 (en) 1982-05-19
IE49267B1 (en) 1985-09-04
FI70702C (fi) 1986-10-06
AU5564980A (en) 1980-08-28
IE800327L (en) 1980-08-21
ES488656A1 (es) 1980-09-16

Similar Documents

Publication Publication Date Title
PT71744B (en) Substituted beta-carbolin-3-carboxylic acid derivatives
NZ193353A (en) Herbicidal -azolyloxyalkanoic acid amides
JPS5625146A (en) 33aminopropanesulfonic acid derivative
ZA80902B (en) N-substituted aziridine-2-carboxylic acid derivatives
GB2058782B (en) Polyprenylcarboxylic acid amides
GB2117774B (en) Oximinoacetic acid derivatives
GB2052484B (en) Epoxysuccinyl amino acid derivatives
KE3362A (en) Herbicidal heterocyclically-substituted 4-oxyphenoxyalkanecarboxylic acid derivatives
ZA783353B (en) A-acetylenic amino acid derivatives
GB2106896B (en) N-substituted aziridine-2-carboxylic acid derivatives
JPS5612365A (en) Mercaptoacylamino acid derivative
GB2001309B (en) Alpha-halomethyl amino acid derivatives
JPS5677262A (en) Mercaptoacyldihydropyrazolecarboxylic acid derivative
GB2053912B (en) Acylaminobenzoic acid derivatives
JPS5659742A (en) Nnacyllamino acid derivative
AU530997B2 (en) N-substituted aziridine-2-carboxylic acid derivatives
ZA792472B (en) N-substituted triorganostannylhydrocarbylcarboxylic acid
JPS55149251A (en) Substituted pyrrolidinylbenzoic acid derivative
ZA803734B (en) Acylaminobenzoic acid derivatives
GB2038334B (en) O-sulfamoylglycolic acid amide derivatives
JPS5615269A (en) Dihydronicotinic acid derivative
GB2051781B (en) Oxoamino acid derivatives
GB2125035B (en) 6b-halopenicillanic acid derivatives
DE3064939D1 (en) Sulfonylcarboxylic acid derivatives
ZA806246B (en) Oxayohimbane-carboxylic acid derivatives